Therapeutic Advances in Vaccines and Immunotherapy
SJR0.832
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.832 | Q2 | 78.6% | |
| 2024 | — | — | 0.889 | Q2 | 81.1% | |
| 2023 | — | — | 0.726 | Q2 | 76.7% | |
| 2022 | — | — | 0.800 | Q2 | 80.5% | |
| 2021 | — | — | — | 0.0% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2515-1363
ISSN
2515-1355
region
Western Europe
coverage
2017-2026